Federal enforcement priorities continue to impact the life sciences sector, with the DOJ increasingly focused on fraud and abuse, supply chain integrity, and national security issues. 

Please join our experienced panel for a discussion of these evolving DOJ enforcement priorities and how they can impact your practice or business. Topics of discussion will include:

• an overview of current DOJ enforcement priorities;
• DOJ’s revised Corporate Enforcement Policy and Whistleblower Pilot Program;
• rise of federal fraud‑enforcement task forces across DOJ and FTC; and
• practical insights on how to adjust compliance, governance and response strategies to help mitigate these risks.

For question, or for information about registration, contact Ella Peek.